You-Ping Chan

Scientific Director at Adocia

You-Ping Chan has over 30 years of work experience in the pharmaceutical and biotechnology industry. You-Ping is currently serving as the Scientific Director at ADOCIA since May 2016. Prior to that, they worked at Elinys Bioscience as the Founder & President from March 2015 to April 2016.

Before founding Elinys Bioscience, You-Ping held various roles at AVADEL Pharmaceuticals (past FLAMEL Technologies). You-Ping served as the Director of Project Management and Formulation Development from October 2012 to December 2013, where they were responsible for overseeing all R&D drug development programs and leading the project management, chemistry, and formulation departments. From January 2002 to October 2012, they were the Director of Chemistry and Analytical R&D, focusing on project management and pharmaceutical CMC development for early phase clinical studies. Prior to that, they worked as a Senior Research Scientist and Project Leader from August 1992 to December 2001, where they contributed to various R&D programs in biodegradable polymer chemistry, protein formulations, and characterizations.

You-Ping Chan began their education journey in 1983 at the University of Strasbourg, where they pursued an undergraduate degree in Chemistry, which they completed in 1987. You-Ping then went on to pursue a Ph.D. in Chemistry at the same university, where they studied from 1987 to 1990.

Following the completion of their Ph.D., Chan engaged in post-doctoral research at the Massachusetts Institute of Technology from 1990 to 1992. During this time, the specific field of study for this research is not mentioned.

In 1987, Chan also had a brief educational experience at Imperial College London, although no degree or specific field of study is listed.

Later in their career, from 2013 to 2015, Chan attended emlyon business school, where they pursued an Executive MBA. Their studies during this period focused on subjects such as Entrepreneurship/Intrapreneurship, Leadership, Finance, and Valuation.

Links


Org chart

Sign up to view 0 direct reports

Get started